Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria - which can have a devastating impact on tens of thousands of children who are admitted to hospital with severe malaria every year.

Anopheles mosquito

The new paper, Malaria infection and severe disease risks in Africa,  key conclusions included:

  • If we can reduce malaria transmission by a quarter we can halve the rate of children needing emergency care for severe, life-threatening malaria.
  • Supports the current intervention policies - that are focusing on younger children - as the most effective strategy for preventing severe malaria disease.
  • Help in understanding and predicting the age-pattern at which children are hospitalised under different settings, so resources can be focused on the children with the highest risk of needing emergency care.

The research, published in Science, analysed over 6000 paediatric hospital admissions from 35 hospitals across Africa, matching patients to populations where the chances of childhood infection varied from very low to very high. They looked for typical indicators of severe disease in children, including anaemia, cerebral symptoms, and respiratory distress.

Read the full story on the University of Oxford website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.